Caroline Pot

5.0k total citations · 1 hit paper
74 papers, 3.0k citations indexed

About

Caroline Pot is a scholar working on Pathology and Forensic Medicine, Immunology and Molecular Biology. According to data from OpenAlex, Caroline Pot has authored 74 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pathology and Forensic Medicine, 31 papers in Immunology and 17 papers in Molecular Biology. Recurrent topics in Caroline Pot's work include Multiple Sclerosis Research Studies (27 papers), Cholesterol and Lipid Metabolism (10 papers) and Psoriasis: Treatment and Pathogenesis (9 papers). Caroline Pot is often cited by papers focused on Multiple Sclerosis Research Studies (27 papers), Cholesterol and Lipid Metabolism (10 papers) and Psoriasis: Treatment and Pathogenesis (9 papers). Caroline Pot collaborates with scholars based in Switzerland, United States and France. Caroline Pot's co-authors include Vijay K. Kuchroo, Lionel Apétoh, Amit Awasthi, Solenne Vigne, Sheng Xiao, Francisco J. Quintana, Nicole Joller, Howard L. Weiner, Deepak Kumar and Evan Burns and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and The Journal of Cell Biology.

In The Last Decade

Caroline Pot

71 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27

2010 593 citations Lionel Apétoh, Caroline Pot et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Caroline Pot Switzerland	27	1.7k	637	608	446	276	74	3.0k
Eva Martínez‐Cáceres Spain	31	1.6k 1.0×	612 1.0×	550 0.9×	444 1.0×	177 0.6×	126	2.9k
Stephen J. Lalor Ireland	17	2.3k 1.4×	565 0.9×	751 1.2×	400 0.9×	112 0.4×	22	3.4k
Bruce F. Bebo United States	31	2.1k 1.3×	935 1.5×	485 0.8×	429 1.0×	83 0.3×	61	3.7k
Gopal Murugaiyan United States	30	2.0k 1.2×	350 0.5×	1.1k 1.9×	580 1.3×	142 0.5×	44	4.0k
Annette Oturai Denmark	27	855 0.5×	1.2k 1.8×	569 0.9×	450 1.0×	68 0.2×	71	2.3k
Yasuhiro Maeda Japan	25	947 0.6×	171 0.3×	620 1.0×	428 1.0×	161 0.6×	147	2.6k
Yoh Hidaka Japan	30	971 0.6×	318 0.5×	461 0.8×	142 0.3×	161 0.6×	154	3.1k
Mario Galgani Italy	33	1.5k 0.9×	140 0.2×	928 1.5×	425 1.0×	219 0.8×	76	3.3k
Hirofumi Ochi Japan	24	649 0.4×	654 1.0×	323 0.5×	194 0.4×	114 0.4×	89	1.8k
Jinping An United States	18	1.9k 1.2×	276 0.4×	870 1.4×	503 1.1×	165 0.6×	29	3.1k

Countries citing papers authored by Caroline Pot

Since Specialization

Citations

This map shows the geographic impact of Caroline Pot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline Pot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline Pot more than expected).

Fields of papers citing papers by Caroline Pot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline Pot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline Pot. The network helps show where Caroline Pot may publish in the future.

Co-authorship network of co-authors of Caroline Pot

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline Pot. A scholar is included among the top collaborators of Caroline Pot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline Pot. Caroline Pot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vigne, Solenne, Francisco Órtega Ruiz, Bastian Peter, et al.. (2025). Gut-derived metabolites drive Th17 cell pathogenicity in multiple sclerosis. Cell Reports. 44(10). 116326–116326. 1 indexed citations

Cheung, Kenneth, Zhenping Chen, Julien Saint‐Pol, et al.. (2025). Metabolic profiles of the human blood-brain barrier cells treated by TNF-alpha and oxysterols. Biomedicine & Pharmacotherapy. 193. 118853–118853.

Loiola, Rodrigo Azevedo, Julien Saint‐Pol, Lucie Dehouck, et al.. (2024). 25-Hydroxycholesterol attenuates tumor necrosis factor alpha-induced blood-brain barrier breakdown in vitro. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(8). 167479–167479. 11 indexed citations

Phillips, Nicholas E., Marie Théaudin, Renaud Du Pasquier, et al.. (2024). Increased central obesity correlates with physical activity and food processing in recently diagnosed multiple sclerosis. Multiple Sclerosis and Related Disorders. 90. 105808–105808. 1 indexed citations

Leval, Laurence de, Bettina Bisig, Jean‐Philippe Brouland, et al.. (2024). Primary diffuse large B-cell lymphoma of the central nervous system identified with CSF biomarkers. BMC Neurology. 24(1). 250–250. 1 indexed citations

Pot, Caroline, et al.. (2024). Traitements de la sclérose en plaques : mise à jour. Revue Médicale Suisse. 20(871). 837–842. 1 indexed citations

Mathias, Amandine, Sylvain Perriot, Mathieu Canales, et al.. (2023). Ocrelizumab Impairs the Phenotype and Function of Memory CD8 ⁺ T Cells. Neurology Neuroimmunology & Neuroinflammation. 10(2). 20 indexed citations

Pasquier, Renaud Du, et al.. (2023). Troubles cognitifs dans la sclérose en plaques : quand y penser ?. Revue Médicale Suisse. 19(824). 791–793. 1 indexed citations

Chan, Andrew, Christian P. Kamm, Chloé Sieber, et al.. (2022). The Real-World Experiences of Persons With Multiple Sclerosis During the First COVID-19 Lockdown: Application of Natural Language Processing. JMIR Medical Informatics. 10(11). e37945–e37945. 2 indexed citations

10.

Salmen, Anke, Robert Hoepner, Lutz Achtnichts, et al.. (2022). Specific Aspects of Immunotherapy for Multiple Sclerosis in Switzerland—A Structured Commentary, Update 2022. SHILAP Revista de lepidopterología. 7(1). 2–2. 2 indexed citations

11.

Canales‐Rodríguez, Erick J., Marco Pizzolato, Tom Hilbert, et al.. (2021). Comparison of non-parametric T2 relaxometry methods for myelin water quantification. Medical Image Analysis. 69. 101959–101959. 19 indexed citations

12.

Maggi, Pietro, Pascal Sati, Govind Nair, et al.. (2020). Paramagnetic Rim Lesions are Specific to Multiple Sclerosis: An International Multicenter 3T MRI Study. Annals of Neurology. 88(5). 1034–1042. 111 indexed citations

13.

Kaufmann, Marco, Milo A. Puhan, Anke Salmen, et al.. (2020). 60/30: 60% of the Morbidity-Associated Multiple Sclerosis Disease Burden Comes From the 30% of Persons With Higher Impairments. Frontiers in Neurology. 11. 156–156. 11 indexed citations

14.

Maggi, Pietro, Martina Absinta, Pascal Sati, et al.. (2019). The “central vein sign” in patients with diagnostic “red flags” for multiple sclerosis: A prospective multicenter 3T study. Multiple Sclerosis Journal. 26(4). 421–432. 54 indexed citations

15.

Vigne, Solenne, et al.. (2019). Resolution of inflammation during multiple sclerosis. Seminars in Immunopathology. 41(6). 711–726. 96 indexed citations

16.

Guéry, Leslie, Juan Dubrot, Dale Brighouse, et al.. (2014). Ag-Presenting CpG-Activated pDCs Prime Th17 Cells That Induce Tumor Regression. Cancer Research. 74(22). 6430–6440. 53 indexed citations

17.

Berger, Hélène, Frédérique Végran, Federica Gilardi, et al.. (2013). SOCS3 Transactivation by PPARγ Prevents IL-17–Driven Cancer Growth. Cancer Research. 73(12). 3578–3590. 47 indexed citations

18.

Pot, Caroline, Lionel Apétoh, & Vijay K. Kuchroo. (2011). Type 1 regulatory T cells (Tr1) in autoimmunity. Seminars in Immunology. 23(3). 202–208. 132 indexed citations

19.

Pot, Caroline, Lionel Apétoh, Amit Awasthi, & Vijay K. Kuchroo. (2011). Induction of regulatory Tr1 cells and inhibition of TH17 cells by IL-27. Seminars in Immunology. 23(6). 438–445. 123 indexed citations

20.

Pot, Caroline, Lionel Apétoh, Amit Awasthi, & Vijay K. Kuchroo. (2010). Molecular Pathways in the Induction of Interleukin-27-Driven Regulatory Type 1 Cells. Journal of Interferon & Cytokine Research. 30(6). 381–388. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact